Tafamidis meglumine (old)
Central Nervous System
Drugs used in parkinsonism and related disorders
BNF 0409030S0
Data updated April 2025
Download CSV
1items
Dispensed in April 2025
0items
Rolling 12 months
£712
Net ingredient cost · April 2025
Figure 1. Tafamidis meglumine (old): national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to April 2025
Embed this chart
At a glance
- Therapeutic class Drugs used in parkinsonism and related disorders
- Presentations 1 shown
- Average cost / item £712.33
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.
Top presentations, April 2025
The individual products dispensed under Tafamidis meglumine (old) this month.
| Presentation | BNF code | Items | Net ingredient cost |
|---|---|---|---|
| Vyndaqel 20mg capsules | 0409030S0BBAAAA | 1 | £712 |
Source: NHSBSA Prescription Cost Analysis · to April 2025 OGL v3.0
Where Tafamidis meglumine (old) is dispensed
The regions and dispensing practices with the highest Tafamidis meglumine (old) volumes.
Top regions
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
Compare Tafamidis meglumine (old) with
Other medicines in the same BNF section, by prescribing volume.